Japanese Encephalitis Vaccines | United States| PDF | PPT| Case Reports | Symptoms | Treatment

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Japanese Encephalitis Vaccines

  • Japanese Encephalitis Vaccines

    Japanese encephalitis vaccines first became available in the 1950s. One of them was an inactivated mouse brain-derived vaccine (the Nakayama and/or Beijing-1 strain), made by BIKEN and marketed by Sanofi Pasteur as JE-VAX, until production ceased in 2005.

  • Japanese Encephalitis Vaccines

    The other was an inactivated vaccine cultivated on primary hamster kidney cells (the Beijing-3 strain).Three second-generation vaccines have entered markets since then: SA14-14-2, IC51 and ChimeriVax-JE. The live-attenuated SA14-14-2 strain was introduced in China in 1988.

  • Japanese Encephalitis Vaccines

    It is much cheaper than alternative vaccines, and is administered to 20 million Chinese children each year. The statistical study is in progress.

Speaker PPTs

High Impact List of Articles

Conference Proceedings